KUALA LUMPUR, July 29 (Bernama) -- Bursa Malaysia rebounded to close higher on Wednesday on selective buying of defensive stocks after a volatile trading session. IPPFA Sdn Bhd director of investment strategy and country economist Mohd Sedek Jantan said consumer products and services stocks lifted the key index higher, overcoming lingering geopolitical concerns. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) rose 3.08 points to 1,715.56 from yesterday’s close of 1,712.48. The benchmark index, which opened 1.91 points higher at 1,714.39, moved between 1,710.79 and 1,720.59 during the day’s trading. In the broader market, gainers outstripped decliners 550 to 476, while 612 counters were unchanged, 1,129 untraded, and 48 suspended. Turnover rose to 2.96 billion units valued at RM2.48 billion from 2.94 billion units valued at RM2.56 billion on Tuesday.
Novo Nordisk, the maker of obesity drug Wegovy , announced plans to cut 9,000 jobs globally as part of a major restructuring aimed at boosting efficiency and fending off fierce competition from Eli Lilly and compounded drugmakers. Key Developments Restructuring plan: The overhaul is expected to generate annual savings of DKK 8 billion (US$1.25 billion) . Novo also flagged DKK 9 billion in one-off restructuring costs . Headcount reversal: The layoffs will reduce staff to early 2024 levels, following a hiring surge that nearly doubled its workforce over the past five years. Profit warning: This marks Novo’s third profit downgrade in 2025 , with guidance for operating profit growth cut to 4%-10% , from a previous 19%-27%. Market and Competitive Context Eroding momentum: Wegovy and diabetes drug Ozempic have seen slowing US sales , while Lilly’s Zepbound overtook Wegovy in prescriptions earlier this year. Product ...